The Rising Influence of Rising Affluence

[DewDiligence]

ABT’s Freestyle Libre continuous-glucose-monitoring system shows improved real-world results consistent with phase-3 trials:

http://finance.yahoo.com/news/real-world-data-abbotts-freestyle-133000768.html

The new real-world data presented at ATTD further support the conclusions of the randomized controlled clinical studies conducted by Abbott with the FreeStyle Libre system including the IMPACT study published in The Lancet in September 2016. Key findings of the IMPACT trial included (FreeStyle Libre users versus traditional SMBG):

• Glucose monitoring increased to an average of 15 scans per day
• 38 percent reduction in time spent in hypoglycemia (<70 mg/dl)
• 50 percent reduction in serious hypoglycemia (<55 mg/dl)
• 40 percent reduction in time spent in nocturnal hypoglycemia at night (11 p.m. to 6 a.m.)
• No increase in HbA1c at six months

…Abbott's FreeStyle Libre system consists of a small, round sensor worn on the back of the upper arm for up to 14 days, which measures glucose every minute in interstitial fluid through a small filament that is inserted just under the skin and held in place with a small adhesive pad. A reader is scanned over the sensor to get a glucose result painlessly in less than one second.

Freestyle Libre is approved in more than 30 countries and is currently under review by the FDA. ABT thinks it will become a needle-moving product.

Please see #msg-128643298 for related info.